Mfd. by :- Aprazer healthcare (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand name: Inlybest-1
Generic name: Axitinib
Strength: 1mg and 5mg
Manufacturer: Aprazer
Dosage form: Tablet
Indication: Kidney cancer
Storage: Store at room temperature.
Inlybest-1 contains Axitinib as an active substance and it is indicated for the treatment of renal cell carcinoma (a type of cancer that begins in the kidney). This anticancer formulation belongs to a group of medications known as tyrosine kinase inhibitors. Inlybest-1 is available in the form of a tablet and it works by blocking the action of an abnormal protein. Take this medicinal formulation orally and swallow the whole tablet with a glass of water. Follow your dosing instructions as prescribed by your general practitioner.
Axitinib helps in preventing the progression of cancer by causing inhibition of angiogenesis and blocking tumor growth. It selectively blocks the tyrosine kinase receptors VEGFR-1 (vascular endothelial growth factor receptor), VEGFR-2, and VEGFR-3. The formulation is mainly eliminated in the feces (about 41%) with nearly 12% of the original dose as unchanged axitinib. There is also 23% eliminated in the urine, most of which are metabolites.
This effective regimen is used to treat Kidney cancer and it helps in decreasing the spread of cancerous cells. Follow all the instructions carefully and administer the tablet as directed by your physician. Do not increase or decrease the strength of Inlybest-1 and for better efficacy complete your dosing schedule. Monitoring of blood pressure is required during treatment with Inlybest-1 (Axitinib) tablets.
It is important to know the interactions of Inlybest-1 tablets with other drugs and diseases, before starting therapy with this ant-cancer formulation.
Carbamazepine
Etravirine
Leflunomide
Rifampin
Thalidomide
Lorlatinib
Hemorrhagic events
Cardiac failure
GI perforation
Hypertension
Proteinuria
Thyroid dysfunction
Lung toxicity
Avoid consuming alcohol while receiving treatment with Inlybest-1 tablets.
The Inlybest-1 tablet is not indicated for use in the below-mentioned cases. Do not use this medication if any of the following apply to you:-
Hypersensitive to the active ingredients present in the medication.
Allergic to Axitinib.
Mild or major side effects may occur during treatment with Inlybest-1 tablets, if side effects last longer than usual inform your general practitioner as soon as possible.
Mouth sores
Stomach pain
Heartburn
Headache
Dizziness
Rash
Itching
Dry skin
Pale skin
Fast heartbeat
Hair loss
Ringing in the ears
Thirst
Hemorrhoids
Wound or cut that will not heal
Diarrhea
Decrease in appetite
Weight loss
Nausea
Vomiting
Constipation
Tiredness
Weakness
Redness
Swelling
Cough
Joint or muscle pain
Note:- contact your medical professional if any side effects occur and don’t go away easily.
Take the Inlybest-1 tablet as prescribed by your health professional. Make sure to take this cancer-fighting formulation in the same amount as directed by your physician.
If you miss a scheduled dose of Inlybest-1 tablet, contact your medical practitioner immediately to know the ways of coping with the missed or skipped dose.
In case of an overdose, the patient is advised to consult a general practitioner as soon as possible if any unusual symptoms occur.
Inform your physician if you have any pre-existing disorder. Check all the possible benefits and risks before starting treatment with the Inlybest-1 tablet.
Pregnancy
Inlybest-1 (Axitinib) tablets are not recommended for use in pregnant women because they may affect the unborn baby.
Breastfeeding
Do not use Inlybest-1 (Axitinib) tablets in breastfeeding. Talk to your medical provider before starting treatment with Inlybest-1.
Before starting treatment with Inlybest-1 medication, tell your general practitioner if you have skin problems like rash, redness, pain, blisters on the palm of your feet.
Inform your healthcare expert if you have any pre-existing disorder of the heart.
If you experience any allergic reaction after the first dose of Inlybest-1 (Axitinib), be sure to contact your general practitioner.
Do not drive or operate heavy machinery
Do not skip a dose
Do not take more or less of this medication
Do not overdose
Q1- What is Inlybest-1?
Ans- Inlybest-1 contains Axitinib as an active substance and it is indicated for the treatment of renal cell carcinoma (a type of cancer that begins in the kidney). It helps in decreasing the spread of cancerous cells.
Q2- What are the side effects of Inlybest-1?
Ans- Common side effects of Inlybest-1 tablet are:- fever, chills, nausea, diarrhea, skin rash, allergy, headache, etc.
Q3- What happens if I miss a dose of Inlybest-1?
Ans- If you miss a scheduled dose of Inlybest-1 tablet, contact your medical practitioner immediately to know the ways of coping with the missed or skipped dose.
Q4- What happens if I overdose on Inlybest-1?
Ans- In case of an overdose, consult a general practitioner as soon as possible if any unusual symptoms occur.
Q5- Is Inlybest-1 safe for use in pregnant women?
Ans- Inlybest-1 (Axitinib) tablets are not recommended for use in pregnant women because they may affect the unborn baby.
Q6- Is Inlybest-1 safe for use in nursing women?
Ans- The use of Inlybest-1 (Imatinib) tablets is not safe in breastfeeding.
Q7- What is the available strength of Inlybest-1?
Ans- Inlybest-1 (Imatinib) is available in the strength of 1mg and 5mg.
Q8- How is Inlybest-1 administered?
Ans- Administer Inlybest-1 tablets as prescribed by your general practitioner.
Q9- Can I drive after taking Inlybest-1?
Ans- It is not advisable to drive after taking Inlybest-1 because it can cause side effects like drowsiness and dizziness.
Q10- Is alcohol consumption safe during Inlybest-1 therapy?
Ans- Consult it with your health professional, before starting treatment with Inlybest-1 tablet.
Fill the Form
Talk to Executive
Get Tracking
Get Medicines Delivered
